↓ Skip to main content

A phase II study of sorafenib (BAY 43–9006) in recurrent diffuse large B cell lymphoma: an eastern cooperative oncology group study (E1404)

Overview of attention for article published in Journal of Hematology & Oncology, July 2013
Altmetric Badge

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A phase II study of sorafenib (BAY 43–9006) in recurrent diffuse large B cell lymphoma: an eastern cooperative oncology group study (E1404)
Published in
Journal of Hematology & Oncology, July 2013
DOI 10.1186/1756-8722-6-46
Pubmed ID
Authors

Daniel R Greenwald, Hailun Li, Selina M Luger, Ronald S Go, David King, Taral Patel, Randy D Gascoyne, Jill Kolesar, Brad S Kahl, Sandra Horning

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 22%
Lecturer 1 11%
Student > Doctoral Student 1 11%
Professor 1 11%
Student > Bachelor 1 11%
Other 2 22%
Unknown 1 11%
Readers by discipline Count As %
Medicine and Dentistry 5 56%
Mathematics 1 11%
Agricultural and Biological Sciences 1 11%
Computer Science 1 11%
Unknown 1 11%